Theragnosis is a patient-management technique that combines diagnosis and treatment. Theragnosis integrates the domains of tumor diagnosis and therapy in oncology in order to improve upon existing procedures. The prospects for diagnosing disease, directing treatment, and monitoring outcomes bring up a new chapter in precision medicine. To develop efficient new targeted therapies with adequate benefit/risk to patients and a better molecular understanding of how to optimise drug selection, theragnostic encompasses a wide range of subjects, including personalised medicine, pharmacogenomics, and molecular imaging. The imaging agents and medications must be administered efficiently for successful theragnosis applications, resulting in appropriate imaging signal or drug concentration in the targeted disease location.
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece